Phase I Clinical Trial Success of Individualised Immunotherapies
Time: 2:30 pm
day: Track B - Day 1 PM
Details:
- Developing individualised immunotherapy based on advanced genetic engineering and artificial intelligence (AI) technologies
- Exploiting the mechanisms of the immune response to enable patients to defend themselves against cancer
